Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia

BACKGROUND: The majority of acute myeloid leukaemia (AML) patients are over sixty years of age. With current treatment regimens, survival rates amongst these, and also those younger patients who relapse, remain dismal and novel therapies are urgently required. In particular, therapies that have anti...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Khanim, Farhat L., Hayden, Rachel E., Birtwistle, Jane, Lodi, Alessia, Tiziani, Stefano, Davies, Nicholas J., Ride, Jon P., Viant, Mark R., Gunther, Ulrich L., Mountford, Joanne C., Schrewe, Heinrich, Green, Richard M., Murray, Jim A., Drayson, Mark T., Bunce, Chris M.
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2009
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2785482/
https://ncbi.nlm.nih.gov/pubmed/19997560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0008147
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires